| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,
,,,,¶,#
,||,,,,
* Laboratory of Neurotoxicology,
Department of Pharmacology and Experimental Neuroscience,
Center for Neurovirology and Neurodegenerative Disorders,
Department of Pathology and Microbiology,
¶ Olson Center for Women’s Health, Department of Obstetrics Gynecology, and
|| Eppley Institute, University of Nebraska Medical Center, Omaha, NE 68198; and
# Veterans Affairs Medical Center, Omaha, NE 68105
HIV-1 uses mononuclear phagocytes (monocytes, tissue macrophages, and dendritic cells) as a vehicle for its own dissemination and as a reservoir for continuous viral replication. The mechanism by which the host immune system clears HIV-1-infected macrophages is not understood. TRAIL may play a role in this process. TRAIL is expressed on the cell membrane of peripheral immune cells and can be cleaved into a soluble, secreted form. The plasma level of TRAIL is increased in HIV-1-infected patients, particularly those with high viral loads. To study the effect of elevated TRAIL on mononuclear phagocytes, we used recombinant human (rh) TRAIL and human monocyte-derived macrophages (MDM) as an in vitro model. Our results demonstrated rhTRAIL-induced apoptosis in HIV-1-infected MDM and inhibited viral replication, while having a reduced effect on uninfected MDM. HIV-1 infection significantly decreased Akt-1 phosphorylation; rhTRAIL exposure further decreased Akt-1 phosphorylation. Infection with a dominant-negative Akt-1 adenovirus potentiated rhTRAIL-induced apoptosis, while constitutively active Akt-1 blocked rhTRAIL-induced apoptosis in HIV-1-infected MDM. From this data we conclude the death ligand TRAIL preferentially provokes apoptosis of HIV-1-infected MDM, and the mechanism is reliant upon the inhibition of Akt-1 phosphorylation. Understanding this mechanism may facilitate the elimination of HIV-1-infected macrophages and lead to new therapeutic avenues for treatment of HIV-1 infection.
This article has been cited by other articles:
|
|
 |
|
  N. Gasper-Smith, D. M. Crossman, J. F. Whitesides, N. Mensali, J. S. Ottinger, S. G. Plonk, M. A. Moody, G. Ferrari, K. J. Weinhold, S. E. Miller, et al. Induction of Plasma (TRAIL), TNFR-2, Fas Ligand, and Plasma Microparticles after Human Immunodeficiency Virus Type 1 (HIV-1) Transmission: Implications for HIV-1 Vaccine Design J. Virol., August 1, 2008; 82(15): 7700 - 7710. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Noursadeghi, J. Tsang, R. F. Miller, and D. R. Katz Comment on "Transcription Factor FOXO3a Mediates Apoptosis in HIV-1-Infected Macrophages" J. Immunol., June 15, 2008; 180(12): 7783 - 7783. [Full Text] [PDF]
|
|
|
|
|
|
Y. Huang, M. Cui, N. Erdmann, A. A. Constantino, Y. Zhao, and J. Zheng Response to Comment on "Transcription Factor FOXO3a Mediates Apoptosis in HIV-1-Infected Macrophages" J. Immunol., June 15, 2008; 180(12): 7783 - 7784. [Full Text] [PDF]
|
|
|
|
 |
|
 A S-Y Leong, P Wannakrairot, and T Y-M Leong Apoptosis is a major cause of so-called "caseous necrosis" in mycobacterial granulomas in HIV-infected patients J. Clin. Pathol., March 1, 2008; 61(3): 366 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cui, Y. Huang, Y. Zhao, and J. Zheng Transcription Factor FOXO3a Mediates Apoptosis in HIV-1-Infected Macrophages J. Immunol., January 15, 2008; 180(2): 898 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Kelly, A. M. C. ten Bokum, S. M. O'Leary, M. P. O'Sullivan, and J. Keane Bystander Macrophage Apoptosis after Mycobacterium tuberculosis H37Ra Infection Infect. Immun., January 1, 2008; 76(1): 351 - 360. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
